Article
The relationship between methylenetetrahydrofolate reductase polymorphism and hematological malignancy.
Clinical laboratory - 1 Jan 2014
Jiang Ni, Zhu Xishan, Zhang Hongmei, Wang Xiaoli, Zhou Xinna, Gu Jiezhun, Chen Baoan, Ren Jun
Abstract excerpt
BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) is the key enzyme for folate metabolism. Previous studies suggest a relationship between its single nucleotide polymorphisms (SNP) of C677T and A1298C with a variety of tumor susceptibility including hematological malignancy. SNP frequency distribution in different ethnic populations might lead to differences in disease susceptibility. There has been little...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
